WestEnd Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
WestEnd Advisors's MRK Position: Q3 2026 in Review
WestEnd Advisors held its Merck (MRK) position steady in Q3 2026 at 73 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #110.
WestEnd Advisors first reported a position in MRK in Q3 2019 and has held it in 19 quarters since. The position peaked at $42.6M in Q1 2024. 2,589 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- WestEnd Advisors held 73 shares of Merck worth $10.6K as of Q3 2026.
- WestEnd Advisors left its Merck share count unchanged in Q3 2026.
- Merck made up ﹤0.01% of WestEnd Advisors's portfolio in Q3 2026, its #110 holding.
- WestEnd Advisors first reported a position in Merck in Q3 2019 and has held it in 19 quarters since.
- WestEnd Advisors's Merck position peaked at $42.6M in Q1 2024.
- 2,589 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on WestEnd Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.